GSK to use 23andMe’s DNA library in drug development

DNA testing company 23andMe has partnered with pharmaceutical giant GlaxoSmithKline (GSK), in a bid to develop new drug treatments. 23andMe, which gives customers insight into their genetic makeup via postal saliva tests, has some five million custom...

Apple entices its first big drug company to ResearchKit

Although Apple's ResearchKit is almost two years old, the platform has mainly been reserved for clinical studies hosted by universities and medical researchers. Hundreds of thousands of people are already contributing data for studies focusing on ast...

Alli Weight Loss Products Recalled


GlaxoSmithKline (GSK) Consumer Healthcare has received complaints about its Alli weight loss products from seven states. That is why, GSK has announced yesterday that it is "voluntarily recalling all...

My Stock-picking Record: A Warts And All Retrospective


As we enter 2014, it is appropriate to review my recent stock-picking record. After a year of excellent success in 2012, I have to admit that my performance in 2013 has been a mixed bag. On the one...
    






August 2014 Options Now Available For GlaxoSmithKline (GSK)


Investors in GlaxoSmithKline plc (NYSE: GSK) saw new options become available today, for the August 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,...
    






The Avorn-Stossel Debate On GSK Halting Payment To Doctors For Drug Promotion


GSK recently announced that it would no longer pay doctors to promote its drugs, a move that has generated a good deal of discussion.  The PBS Newshour entered the fray by featuring a debate between...
    






World’s First Malaria Vaccine Needs Regulatory Approval


A conference took place in South Africa in which the suitability of the RTS, S vaccine was discussed. It was clearly shown that in case of small children who had been vaccinated there was a 46%...